Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05027867
Title KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Kartos Therapeutics, Inc.
Indications

lung small cell carcinoma

Therapies

KRT-232

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU

Additional content available in CKB BOOST